Retraction Notice: Improved Antitumor Activity in Colon Cancer Utilizing EGF-Modified PLGA Nanoparticles Loaded with 5-Fluorouracil and Perfluorocarbon

Background

The integrity of scientific research is paramount, particularly in oncology. Retractions serve as a mechanism to maintain the reliability of published literature. This article's retraction highlights the importance of scrutiny in research methodologies and data presentation.

Data Highlights

No numerical or trial data is presented due to the retraction of the article.

Key Findings

• The article was retracted due to post-publication concerns about image similarities.
• The authors did not respond to inquiries regarding the integrity of the data.
• The editors expressed a lack of confidence in the article’s conclusions.

Clinical Implications

Healthcare professionals should remain vigilant regarding the integrity of research findings, particularly in oncology. The retraction serves as a reminder of the need for transparency and accountability in scientific publishing.

Conclusion

The retraction of this article underscores the critical importance of maintaining high standards in research integrity. Ongoing scrutiny is essential to uphold the trustworthiness of scientific literature.

Related Resources & Content

1. BMC Cancer, 2020 -- Retraction Notice: Improved Antitumor Activity in Colon Cancer Utilizing EGF-Modified PLGA Nanoparticles Loaded with 5-Fluorouracil and Perfluorocarbon
2. the asco post — Omitting 5-FU Bolus May Reduce Side Effects in Patients With Gastrointestinal Cancers
3. The ASCO Post — Report Highlights Rapid Adoption of Clinical Research Results Into Colon Cancer Chemotherapy Prescribing Patterns
4. Monotherapy with sorafenib or 5-FU demonstrates comparable efficacy in human colorectal cancer xenografts—no advantage observed with combination treatment
5. the asco post — Report Highlights Rapid Adoption of Clinical Research Results Into Colon Cancer Chemotherapy Prescribing Patterns
6. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up - PubMed
7. Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer | New England Journal of Medicine
8. Advances in PLGA-based polymeric nanocarriers for colorectal cancer therapy: overcoming chemoresistance through controlled delivery strategies | Molecular Cancer | Springer Nature Link